scholarly journals Physical activity and prodromal features of Parkinson disease

Neurology ◽  
2019 ◽  
Vol 93 (23) ◽  
pp. e2157-e2169 ◽  
Author(s):  
Katherine C. Hughes ◽  
Xiang Gao ◽  
Samantha Molsberry ◽  
Linda Valeri ◽  
Michael A. Schwarzschild ◽  
...  

ObjectiveTo investigate the relationship between physical activity and prodromal features of Parkinson disease that often precede the clinical diagnosis.MethodsIncluded are participants in 2 well-established cohorts: the Nurses' Health Study and the Health Professionals Follow-up Study. Physical activity was assessed using validated questionnaires at baseline (1986) and every 2 years until 2008. Prodromal features (e.g., constipation, hyposmia, and probable REM sleep behavior disorder [pRBD]) were assessed in 2012–2014.ResultsThe multivariable-adjusted odds ratio (OR) for having ≥3 prodromal features vs none comparing the highest to the lowest quintile were 0.65 (95% confidence interval [CI] 0.53–0.79; ptrend = 0.0006) for baseline physical activity and 0.52 (95% CI 0.35–0.76; ptrend = 0.009) for cumulative average physical activity. Considering each feature independently, baseline physical activity was associated with lower odds of constipation (OR 0.78, 95% CI 0.73–0.83; ptrend < 0.0001), excessive daytime sleepiness (OR 0.72, 95% CI 0.60–0.86; ptrend = 0.002), depressive symptoms (OR 0.82, 95% CI 0.69–0.97; ptrend = 0.13), and bodily pain (OR 0.81, 95% CI 0.68–0.96; ptrend = 0.03). Similar or stronger associations were observed for cumulative average physical activity, which, in addition, was associated with pRBD (OR 0.85, 95% CI 0.77–0.95; ptrend = 0.02). In contrast, neither hyposmia nor impaired color vision was associated with physical activity. Early life physical activity was associated with constipation and, in men only, with the co-occurrence of ≥3 features.ConclusionsThe reduced prevalence of prodromal features associated with Parkinson disease in older individuals who were more physically active in midlife and beyond is consistent with the hypothesis that high levels of physical activity may reduce risk of Parkinson disease.

Neurology ◽  
2019 ◽  
Vol 93 (6) ◽  
pp. 259-266 ◽  
Author(s):  
Abhishek Lenka ◽  
Javier Pagonabarraga ◽  
Pramod Kumar Pal ◽  
Helena Bejr-Kasem ◽  
Jaime Kulisvesky

ObjectivePsychosis is one of the most debilitating complications of Parkinson disease (PD). Although research on PD psychosis has been focused on the study of well-structured visual hallucinations (VH), currently accepted National Institute of Neurological Disorders and Stroke–National Institute of Mental Health diagnostic criteria emphasize minor hallucinations (MH) as the most common psychotic phenomena in PD. The objective of this review is to comprehensively describe the clinical and research advances on the understanding of MH and to provide future directions for obtaining further insights into their potential major implications for PD management and prognosis.MethodsA PubMed search was done in November 2018 to identify articles on minor psychotic phenomena in PD.ResultsMH often precede the onset of well-structured VH and are associated with other nonmotor symptoms such as REM sleep behavior disorder and depression. The pattern of functional brain connectivity changes associated with MH involve visual-processing areas and attention control networks, which overlap with abnormalities described in patients with well-structured VH. The dysfunction of cortical networks in patients with MH may be an early indicator of a more widespread form of the disease.ConclusionAlthough called “minor,” MH may have major clinical and prognostic implications. Further research is needed to establish whether MH are associated with a higher risk of disabling psychotic complications, cognitive deterioration, or a more accelerated disease progression. Understanding the early neurobiological underpinnings of MH may provide the background for future studies to identify the progressive dysfunction of neural circuits leading to more severe forms of psychosis in PD.


SLEEP ◽  
2015 ◽  
Vol 38 (10) ◽  
pp. 1529-1535 ◽  
Author(s):  
Isabelle Arnulf ◽  
Dulce Neutel ◽  
Bastien Herlin ◽  
Jean-Louis Golmard ◽  
Smaranda Leu-Semenescu ◽  
...  

2014 ◽  
Vol 20 (4) ◽  
pp. 444-446 ◽  
Author(s):  
Young Eun Kim ◽  
Hui June Yang ◽  
Ji Young Yun ◽  
Han-Joon Kim ◽  
Jee-Young Lee ◽  
...  

SLEEP ◽  
2011 ◽  
Vol 34 (8) ◽  
pp. 1119-1125 ◽  
Author(s):  
Peternella S. Verhave ◽  
Marjan J. Jongsma ◽  
Roland M. Van den Berg ◽  
José C. Vis ◽  
Raymond A.P. Vanwersch ◽  
...  

2007 ◽  
Vol 13 ◽  
pp. S43-S44
Author(s):  
Y.H. Sohn ◽  
J.-S. Kim ◽  
K. Kim ◽  
J.E. Lee ◽  
H.-W. Shin

2020 ◽  
Vol 16 (3) ◽  
pp. 385-388 ◽  
Author(s):  
Whitney H. Whitfield ◽  
Garrett Q. Barr ◽  
Matthew J. Khayata ◽  
Peggy H. Vogt ◽  
Eric M. Keasler ◽  
...  

Neurology ◽  
2018 ◽  
Vol 91 (10) ◽  
pp. e894-e905 ◽  
Author(s):  
Gennaro Pagano ◽  
Rosa De Micco ◽  
Tayyabah Yousaf ◽  
Heather Wilson ◽  
Avinash Chandra ◽  
...  

ObjectiveTo investigate whether REM sleep behavior disorder (RBD) is associated with worse motor and cognitive decline in Parkinson disease (PD)MethodsFour-hundred twenty-one drug-naive patients with early-stage PD and 196 controls without PD were included in this study. All participants underwent a [123I]FP-CIT SPECT scan, CSF assessment, 3-tesla MRI, and thorough clinical assessments.ResultsAt cross-sectional analyses, patients with PD and probable RBD (PD-RBD) had lower CSF β-amyloid 1–42 (Aβ42) levels and higher total tau to Aβ42 CSF ratio, higher nonmotor symptoms burden, and worse scores on neuropsychological tests of processing speed, visuospatial functioning, and delayed recognition memory compared to patients with PD without RBD. At longitudinal analyses, the presence of RBD was associated with faster motor progression (hazard ratio [HR] = 1.368, 95% confidence Interval [CI] = 1.036–1.806; p = 0.027) and cognitive decline (HR = 1.794, 95% CI = 1.163–2.768; p = 0.008) over 60-month follow-up. The presence of RBD was a predictor for motor progression only in patients with PD who had both low α-synuclein levels and low [123I]FP-CIT uptake in the striatum (HR = 2.091, 95% CI = 1.116–3.918; p = 0.021) and a predictor for cognitive decline only in patients with PD who had both low Aβ42 and low α-synuclein levels (HR = 2.810, 95% CI = 1.462–5.400; p = 0.002). In the population of controls without PD, the presence of RBD was not associated with cognitive decline or any baseline pathologic changes.ConclusionThe presence of RBD in PD is associated with faster motor progression in patients with greater synuclein and dopaminergic pathology, and with higher risk of cognitive decline in patients with greater synuclein and amyloid pathology. Our findings provide an important direction toward understanding phenotypes and their prognosis in PD.


Sign in / Sign up

Export Citation Format

Share Document